作为首家成立供应链金融事业部的商业银行，民生银行是供应链金融服务的创新先行者。近年来，民生 银行持续创新供应链产品，形成涵盖"供、产、销"，覆盖核心企业强增信、脱核供应链、小微泛供应链 等的"民生E链"产品谱系，打造便利化、差异化、智能化的行业解决方案，为供应链上客户提供结算、 融资、供应链管理等一体化服务，推动供应链金融业务规模实现快速增长,"民生E链"特色品牌初具市场 影响力。 随着信息技术飞速发展，产业分工日益细化，企业经营布局已从单纯追求规模扩张转向构建智慧、绿色 和负责任的供应链生态系统。这既是企业适应全球产业链重构的必然选择，也是提升企业竞争力、实现 长期价值创造的核心策略。与此同时，银行供应链金融业务在其中也发挥着越来越重要的作用。 民生银行"民生E链"产品可针对不同企业制定个性化服务方案，实现标准化与特色化相结合，线上线下 相结合，数据增信与风险决策相结合；多渠道快速对接客户数据，减少客户网点交付环节，基于大数据 实现多维度客户画像，通过数字技术优化授信审批和放款流程，实现风险控制和资金精准投放，简化企 业操作，提升业务效率。 民生银行青岛分行依托总行"民生E链"产品谱系，通过科技创新、数字赋 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本文件內容概不負責，對其準確性或完整性亦不發表任何 聲明，並明確表示，概不對因本件全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 UBA INVESTMENTS LIMITED 開明投資有限公司* ( 於開曼群島註冊成立之有限公司 ) (股份代號：768) 截至二零二五年三月三十一日止年度 年三月三十一日止年度 全年業績公告 業績 開明投資有限公司（「本公司」）董事會（「董事會」）欣然提呈公司及其附屬公司（「本集團」）截 至二零二五年三月三十一日止年度之綜合業績連同上財政年度之審核比較數字分列如下： 綜合損益表及其它收益表 截至二零二五年三月三十一日止年度 | | | 二零二五年 | 二零二四年 | | --- | --- | --- | --- | | | 附註 | 千港元 | 千港元 | | 出售交易證券的所得款項總額 | | 59,591 | 2,882 | | 收入 | 4 | 5,042 | 5,010 | | 按公平值變動於損益賬列賬之財務資產之收益/(虧損)淨額 | 5 | 10,228 | (7,690) | | 出售附 ...

Investor Presentation June 2025 Safe Harbor Disclosure We make forward-looking statements in this presentation that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, cash flow and plans and objectives. When we use the words "believe," "expect," "anticipate," "estimate," "plan," "continue," "intend," "should," "may" or similar expressions, we intend to id ...

Core Insights - BIO-key International, Inc. has joined ISMS Forum, Spain's leading cybersecurity association, to enhance its commitment to cybersecurity resilience and robust security strategies in Spain [1][2] - The collaboration aims to drive innovation in identity and access management, Zero Trust security, and regulatory compliance [2] Company Overview - BIO-key is a leader in Identity and Access Management (IAM) and biometric authentication solutions, securing access for over 40 million users [4] - The company offers a range of authentication options, including phoneless, tokenless, and passwordless biometric solutions, through its PortalGuard IAM software [4] Industry Context - ISMS Forum promotes best practices, innovation, and knowledge-sharing to strengthen cybersecurity resilience across various industries in Spain [3] - The organization plays a key role in shaping the cybersecurity landscape through working groups, research initiatives, and conferences [3]

尽管国际油价在暴跌后有所稳定，CBOT豆油止跌企稳，马来西亚棕榈油期货小幅走高，但国内油脂主 力合约周三仍录得连续第三日下跌，其中，棕榈油主力合约收低0.36%，豆油主力合约小幅收跌 0.25%，而菜油午后再创逾一周新低至9442元，最终收跌1.36%，报收9476元/吨，市场分析认为，仍需 关注国内菜籽买船以及中加贸易关系实际走向。 马来西亚棕榈油6月库存压力或将有所缓解 马棕油方面，截至目前的数据显示，马棕油6月出口增幅高于产量增幅，市场预计马来西亚棕榈油6月库 存压力将有所缓解。 国内豆油供应较为宽松，对价格产生压制作用 国内方面，国家粮油信息中心数据显示，上周我国豆油、菜油和棕榈油商业库存均上升。6月20日，三 大油脂商业库存206万吨，周环比上升7万吨，月环比上升21万吨，同比上升26万吨。其中豆油库存89万 吨，周环比上升4万吨，月环比上升19万吨，同比下降13万吨；菜籽油75万吨，周环比上升1万吨，月环 比下降4万吨，同比上升38万吨；棕榈油42万吨，周环比上升2万吨，月环比上升6万吨，同比上升1万 吨。 具体来看，出口方面，今日发布的数据显示，马来西亚独立检验机构AmSpec表示，马来西亚6月 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 Twintek Investment Holdings Limited 乙德投資控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：6182） 截至二零二五年三月三十一日止年度之 年度業績 | | | 財務摘要 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | 截至三月三十一日止年度 | | | | | | | | | | 二零二五年 | | 二零二四年 | | | 收 | 益 | | | | | 207.2百萬港元 | | 102.5百萬港元 | | | 毛 | 利 | | | | | 36.2百萬港元 | | 9.4百萬港元 | | | 除 | 稅 | 後 | 淨 溢 | 利（虧 | 損） | 1.3 ...

Investor Presentation May 2025 Forward Looking Statements & Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known eve ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因 依賴該等內容而引致的任何損失承擔任何責任。 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：8221） 截至二零二五年三月三十一日止年度的 全年業績公告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上市的公 司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並應經過審慎周 詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較在聯交所主板買賣之證 券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 本公告乃遵照聯交所GEM證券上市規則（「GEM上市規則」）而提供有關高裕金融集團有限公司 （「本公司」）的資料，本公司董事（「董事」）願共同及個別就此負全責。董事在作出一切合理查 詢後確認，就彼等所深知及確信，本公告所載資料在所有重大方面均屬準確完整，並無誤導或 欺詐成份 ...

Company Overview - ZyVersa Therapeutics, Inc. is a clinical stage specialty biopharmaceutical company focused on developing first-in-class drugs for renal and inflammatory diseases with significant unmet medical needs [5] - The company is advancing a therapeutic development pipeline that includes Cholesterol Efflux Mediator™ VAR 200 for kidney diseases and Inflammasome ASC Inhibitor IC 100 for inflammatory diseases [5] Share Purchase Agreement (SPA) - ZyVersa has entered into a share purchase agreement with Williamsburg Venture Holdings, allowing the company to sell up to $10 million worth of common stock over a 24-month period [3] - The SPA provides ZyVersa with flexibility in planning the timing and amount of equity sales, aiming to minimize dilution while sustaining shareholder value [2][3] - ZyVersa retains control over the timing and amount of all common stock sales, with no associated warrants or derivatives [3] Market Potential - The global drug market for kidney diseases was valued at $18 billion in 2024 and is projected to reach $30 billion by 2034 [1]

Global Leader in Advanced Security and Surveillance Technology & Industrial Services NASDAQ Listed | CETX Investor Presentation January 2025 | Share Price1 | $2.84 | | --- | --- | | Market Cap1 | $4.9M | | FY 2024 Revenue2 | $66.9M | | Cash & Cash Equivalents2 | $3.9M | | Shares Outstanding3 | 1.7M | | Float3 | 1.7M | | Headquarters | Hauppauge, NY | | Employees | 281 | Safe Harbor Statement This presentation may contain forward looking statements that involve numerous risks and uncertainties. Actual result ...